---
schema_version: "secwatch.filing_event.v1"
accession: "0001798749-23-000042"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:10:00.594339+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Aerovate stockholders elect Dorval and Resnick as Class II directors; ratify KPMG as auditor

## Summary
- Allison Dorval elected with 18,685,353 votes for and 366,333 withheld; Joshua Resnick elected with 18,169,764 for and 881,922 withheld.
- Ratification of KPMG LLP as independent auditor for FY2023 passed with 21,184,481 votes for, 0 against, 201 abstain.
- Meeting held June 6, 2023; no other matters voted on.

## SEC filing metadata
- accession: 0001798749-23-000042
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/0001798749-23-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/tmb-20230606x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001798749-23-000042
- JSON: https://secwatch.observer/filing/0001798749-23-000042.json
- Plain text: https://secwatch.observer/filing/0001798749-23-000042.txt

## Key facts
- Shareholder Votes
  Jade Biosciences, Inc. shareholders approved Elect each of Allison Dorval and Joshua Resnick, M.D. as Class II directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee Votes For Votes Withheld Broker Non-Votes Allison Dorval 18,685,353 366,333 2,132,996 Joshua Resnick, M.D. 18,169,764 881,922 2,132,996
  evidence_url: https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/0001798749-23-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.